ID   P3C2G_HUMAN             Reviewed;        1445 AA.
AC   O75747; A1L3U0;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 3.
DT   10-MAY-2017, entry version 161.
DE   RecName: Full=Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma;
DE            Short=PI3K-C2-gamma;
DE            Short=PtdIns-3-kinase C2 subunit gamma;
DE            EC=2.7.1.154;
DE   AltName: Full=Phosphoinositide 3-kinase-C2-gamma;
GN   Name=PIK3C2G;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT LEU-911.
RC   TISSUE=Liver, Mammary gland, and Prostate;
RX   PubMed=9878262; DOI=10.1006/geno.1998.5621;
RA   Rozycka M., Lu Y.-J., Brown R.A., Lau M.R., Shipley J.M., Fry M.J.;
RT   "cDNA cloning of a third human C2-domain-containing class II
RT   phosphoinositide 3-kinase, PI3K-C2gamma, and chromosomal assignment of
RT   this gene (PIK3C2G) to 12p12.";
RL   Genomics 54:569-574(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS LEU-146
RP   AND LEU-911.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS LEU-146 AND
RP   LEU-911.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Prostate cancer;
RX   PubMed=17487921; DOI=10.1002/elps.200600782;
RA   Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
RT   "Toward a global characterization of the phosphoproteome in prostate
RT   cancer cells: identification of phosphoproteins in the LNCaP cell
RT   line.";
RL   Electrophoresis 28:2027-2034(2007).
RN   [6]
RP   VARIANT LEU-146.
RX   PubMed=17991425; DOI=10.1016/j.bbrc.2007.10.180;
RA   Daimon M., Sato H., Oizumi T., Toriyama S., Saito T., Karasawa S.,
RA   Jimbu Y., Wada K., Kameda W., Susa S., Yamaguchi H., Emi M.,
RA   Muramatsu M., Kubota I., Kawata S., Kato T.;
RT   "Association of the PIK3C2G gene polymorphisms with type 2 DM in a
RT   Japanese population.";
RL   Biochem. Biophys. Res. Commun. 365:466-471(2008).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.25 ANGSTROMS) OF 1204-1307.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of the phox homology domain of human
RT   phosphoinositide-3-kinase-C2-gamma.";
RL   Submitted (NOV-2009) to the PDB data bank.
CC   -!- FUNCTION: Generates phosphatidylinositol 3-phosphate (PtdIns3P)
CC       and phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) that act
CC       as second messengers. May play a role in SDF1A-stimulated
CC       chemotaxis (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + 1-phosphatidyl-1D-myo-inositol 4-
CC       phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Peripheral membrane
CC       protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in liver, prostate and
CC       testis. Lower levels in small intestine, kidney and pancreas.
CC       {ECO:0000269|PubMed:9878262}.
CC   -!- SIMILARITY: Belongs to the PI3/PI4-kinase family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00879, ECO:0000255|PROSITE-
CC       ProRule:PRU00880}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA03853.1; Type=Erroneous termination; Positions=1446; Note=Translated as stop.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ000008; CAA03853.1; ALT_SEQ; mRNA.
DR   EMBL; AC087236; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC087240; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091815; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092851; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471094; EAW96387.1; -; Genomic_DNA.
DR   EMBL; BC130277; AAI30278.1; -; mRNA.
DR   CCDS; CCDS44839.1; -.
DR   PIR; PC4347; PC4347.
DR   RefSeq; NP_001275701.1; NM_001288772.1.
DR   RefSeq; NP_001275703.1; NM_001288774.1.
DR   RefSeq; NP_004561.3; NM_004570.5.
DR   UniGene; Hs.22500; -.
DR   PDB; 2WWE; X-ray; 1.25 A; A=1204-1307.
DR   PDBsum; 2WWE; -.
DR   ProteinModelPortal; O75747; -.
DR   SMR; O75747; -.
DR   STRING; 9606.ENSP00000266497; -.
DR   BindingDB; O75747; -.
DR   ChEMBL; CHEMBL1163120; -.
DR   GuidetoPHARMACOLOGY; 2288; -.
DR   iPTMnet; O75747; -.
DR   PhosphoSitePlus; O75747; -.
DR   PaxDb; O75747; -.
DR   PeptideAtlas; O75747; -.
DR   PRIDE; O75747; -.
DR   Ensembl; ENST00000266497; ENSP00000266497; ENSG00000139144.
DR   Ensembl; ENST00000433979; ENSP00000404845; ENSG00000139144.
DR   GeneID; 5288; -.
DR   KEGG; hsa:5288; -.
DR   UCSC; uc001rdt.4; human.
DR   CTD; 5288; -.
DR   DisGeNET; 5288; -.
DR   GeneCards; PIK3C2G; -.
DR   H-InvDB; HIX0036732; -.
DR   HGNC; HGNC:8973; PIK3C2G.
DR   MIM; 609001; gene.
DR   neXtProt; NX_O75747; -.
DR   OpenTargets; ENSG00000139144; -.
DR   PharmGKB; PA33306; -.
DR   eggNOG; KOG0905; Eukaryota.
DR   eggNOG; COG5032; LUCA.
DR   GeneTree; ENSGT00760000119110; -.
DR   HOGENOM; HOG000168239; -.
DR   HOVERGEN; HBG053398; -.
DR   InParanoid; O75747; -.
DR   KO; K00923; -.
DR   PhylomeDB; O75747; -.
DR   TreeFam; TF102031; -.
DR   BioCyc; MetaCyc:HS06583-MONOMER; -.
DR   BRENDA; 2.7.1.137; 2681.
DR   BRENDA; 2.7.1.154; 2681.
DR   Reactome; R-HSA-1660499; Synthesis of PIPs at the plasma membrane.
DR   Reactome; R-HSA-1660514; Synthesis of PIPs at the Golgi membrane.
DR   EvolutionaryTrace; O75747; -.
DR   GeneWiki; PIK3C2G; -.
DR   GenomeRNAi; 5288; -.
DR   PRO; PR:O75747; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000139144; -.
DR   CleanEx; HS_PIK3C2G; -.
DR   ExpressionAtlas; O75747; baseline and differential.
DR   Genevisible; O75747; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005942; C:phosphatidylinositol 3-kinase complex; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0016303; F:1-phosphatidylinositol-3-kinase activity; IBA:GO_Central.
DR   GO; GO:0035005; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IEA:InterPro.
DR   GO; GO:0016307; F:phosphatidylinositol phosphate kinase activity; NAS:UniProtKB.
DR   GO; GO:0006935; P:chemotaxis; IEA:UniProtKB-KW.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; IEA:InterPro.
DR   GO; GO:0039694; P:viral RNA genome replication; IMP:ParkinsonsUK-UCL.
DR   Gene3D; 1.10.1070.11; -; 1.
DR   Gene3D; 2.60.40.150; -; 2.
DR   Gene3D; 3.30.1520.10; -; 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR001683; Phox.
DR   InterPro; IPR000403; PI3/4_kinase_cat_dom.
DR   InterPro; IPR018936; PI3/4_kinase_CS.
DR   InterPro; IPR002420; PI3K_C2_dom.
DR   InterPro; IPR000341; PI3K_Ras-bd_dom.
DR   InterPro; IPR015433; PI_Kinase.
DR   InterPro; IPR001263; PInositide-3_kin_accessory_dom.
DR   InterPro; IPR029071; Ubiquitin-rel_dom.
DR   PANTHER; PTHR10048; PTHR10048; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00454; PI3_PI4_kinase; 1.
DR   Pfam; PF00794; PI3K_rbd; 1.
DR   Pfam; PF00613; PI3Ka; 1.
DR   Pfam; PF00787; PX; 1.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00145; PI3Ka; 1.
DR   SMART; SM00146; PI3Kc; 1.
DR   SMART; SM00312; PX; 1.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   SUPFAM; SSF49562; SSF49562; 2.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF64268; SSF64268; 1.
DR   PROSITE; PS00915; PI3_4_KINASE_1; 1.
DR   PROSITE; PS00916; PI3_4_KINASE_2; 1.
DR   PROSITE; PS50290; PI3_4_KINASE_3; 1.
DR   PROSITE; PS51547; PI3K_C2; 1.
DR   PROSITE; PS51546; PI3K_RBD; 1.
DR   PROSITE; PS51545; PIK_HELICAL; 1.
DR   PROSITE; PS50195; PX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Chemotaxis; Complete proteome; Kinase;
KW   Membrane; Nucleotide-binding; Polymorphism; Reference proteome;
KW   Transferase.
FT   CHAIN         1   1445       Phosphatidylinositol 4-phosphate 3-kinase
FT                                C2 domain-containing subunit gamma.
FT                                /FTId=PRO_0000088799.
FT   DOMAIN      285    371       PI3K-RBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00879}.
FT   DOMAIN      453    628       C2 PI3K-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00880}.
FT   DOMAIN      643    819       PIK helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00878}.
FT   DOMAIN      916   1180       PI3K/PI4K. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00269}.
FT   DOMAIN     1199   1311       PX. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00147}.
FT   DOMAIN     1328   1424       C2.
FT   VARIANT     146    146       P -> L (in dbSNP:rs11044004).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17991425,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_056676.
FT   VARIANT     261    261       A -> E (in dbSNP:rs7133666).
FT                                /FTId=VAR_056677.
FT   VARIANT     911    911       P -> L (in dbSNP:rs12312266).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9878262,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_060323.
FT   VARIANT    1290   1290       V -> G (in dbSNP:rs12099555).
FT                                /FTId=VAR_060324.
FT   VARIANT    1442   1442       N -> T (in dbSNP:rs12816860).
FT                                /FTId=VAR_060325.
FT   CONFLICT    129    129       Missing (in Ref. 3; EAW96387 and 4;
FT                                AAI30278). {ECO:0000305}.
FT   CONFLICT    965    965       G -> R (in Ref. 1; CAA03853).
FT                                {ECO:0000305}.
FT   CONFLICT   1209   1209       Missing (in Ref. 1; CAA03853).
FT                                {ECO:0000305}.
FT   CONFLICT   1314   1314       Missing (in Ref. 1; CAA03853).
FT                                {ECO:0000305}.
FT   CONFLICT   1323   1323       E -> EK (in Ref. 1; CAA03853).
FT                                {ECO:0000305}.
FT   CONFLICT   1377   1377       R -> L (in Ref. 1; CAA03853).
FT                                {ECO:0000305}.
FT   STRAND     1204   1214       {ECO:0000244|PDB:2WWE}.
FT   STRAND     1217   1227       {ECO:0000244|PDB:2WWE}.
FT   STRAND     1232   1237       {ECO:0000244|PDB:2WWE}.
FT   HELIX      1239   1252       {ECO:0000244|PDB:2WWE}.
FT   TURN       1253   1255       {ECO:0000244|PDB:2WWE}.
FT   HELIX      1267   1271       {ECO:0000244|PDB:2WWE}.
FT   HELIX      1273   1287       {ECO:0000244|PDB:2WWE}.
FT   HELIX      1292   1295       {ECO:0000244|PDB:2WWE}.
FT   HELIX      1298   1305       {ECO:0000244|PDB:2WWE}.
SQ   SEQUENCE   1445 AA;  165715 MW;  8D02A3620AE4318D CRC64;
     MAYSWQTDPN PNESHEKQYE HQEFLFVNQP HSSSQVSLGF DQIVDEISGK IPHYESEIDE
     NTFFVPTAPK WDSTGHSLNE AHQISLNEFT SKSRELSWHQ VSKAPAIGFS PSVLPKPQNT
     NKECSWGSPI GKHHGADDSR FSILAPSFTS LDKINLEKEL ENENHNYHIG FESSIPPTNS
     SFSSDFMPKE ENKRSGHVNI VEPSLMLLKG SLQPGMWEST WQKNIESIGC SIQLVEVPQS
     SNTSLASFCN KVKKIRERYH AADVNFNSGK IWSTTTAFPY QLFSKTKFNI HIFIDNSTQP
     LHFMPCANYL VKDLIAEILH FCTNDQLLPK DHILSVCGSE EFLQNDHCLG SHKMFQKDKS
     VIQLHLQKSR EAPGKLSRKH EEDHSQFYLN QLLEFMHIWK VSRQCLLTLI RKYDFHLKYL
     LKTQENVYNI IEEVKKICSV LGCVETKQIT DAVNELSLIL QRKGENFYQS SETSAKGLIE
     KVTTELSTSI YQLINVYCNS FYADFQPVNV PRCTSYLNPG LPSHLSFTVY AAHNIPETWV
     HRINFPLEIK SLPRESMLTV KLFGIACATN NANLLAWTCL PLFPKEKSIL GSMLFSMTLQ
     SEPPVEMITP GVWDVSQPSP VTLQIDFPAT GWEYMKPDSE ENRSNLEEPL KECIKHIARL
     SQKQTPLLLS EEKKRYLWFY RFYCNNENCS LPLVLGSAPG WDERTVSEMH TILRRWTFSQ
     PLEALGLLTS SFPDQEIRKV AVQQLDNLLN DELLEYLPQL VQAVKFEWNL ESPLVQLLLH
     RSLQSIQVAH RLYWLLKNAE NEAYFKSWYQ KLLAALQFCA GKALNDEFSK EQKLIKILGD
     IGERVKSASD HQRQEVLKKE IGRLEEFFQD VNTCHLPLNP ALCIKGIDHD ACSYFTSNAL
     PLKITFINAN PMGKNISIIF KAGDDLRQDM LVLQLIQVMD NIWLQEGLDM QMIIYRCLST
     GKDQGLVQMV PDAVTLAKIH RHSGLIGPLK ENTIKKWFSQ HNHLKADYEK ALRNFFYSCA
     GWCVVTFILG VCDRHNDNIM LTKSGHMFHI DFGKFLGHAQ TFGGIKRDRA PFIFTSEMEY
     FITEGGKNPQ HFQDFVELCC RAYNIIRKHS QLLLNLLEMM LYAGLPELSG IQDLKYVYNN
     LRPQDTDLEA TSHFTKKIKE SLECFPVKLN NLIHTLAQMS AISPAKSTSQ TFPQESCLLS
     TTRSIERATI LGFSKKSSNL YLIQVTHSNN ETSLTEKSFE QFSKLHSQLQ KQFASLTLPE
     FPHWWHLPFT NSDHRRFRDL NHYMEQILNV SHEVTNSDCV LSFFLSEAVQ QTVEESSPVY
     LGEKFPDKKP KVQLVISYED VKLTILVKHM KNIHLPDGSA PSAHVEFYLL PYPSEVRRRK
     TKSVPKCTDP TYNEIVVYDE VTELQGHVLM LIVKSKTVFV GAINIRLCSV PLDKEKWYPL
     GNSII
//
